The clinical development of biopharmaceuticals is an increasingly competitive and complex space. Organizations with limited prior experience with the drug development lifecycle will embark on a journey requiring plans and strategies to minimize time, resource and impact to budget. In this initial blog, we will identify and provide an …
Examining the Value and Future of Drug Repurposing in Life Sciences
In the Life Sciences industry, many drugs on the market today have been approved for indications for which they were not originally developed. Sometimes, discovering a new use for a drug happens by chance during a clinical trial or post-market, as more information is learned about the drug’s effects that weren’t originally …
